Cited by

• A versatile qPCR assay to quantify trypanosomatidic infections of host cells and tissues.

  Bifeld E, Tejera Nevado P, Bartsch J, Eick J, Clos J. Bifeld E, et al. Med Microbiol Immunol. 2016 Oct;205(5):449-58. doi: 10.1007/s00430-016-0460-3. Epub 2016 Jun 9. Med Microbiol Immunol. 2016. PMID: 27283847
• Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study.

  Martins Barros IM, Barros MVL, Almeida Martins LN, Ribeiro ALP, de Camargo RSS, Oliveira CDL, Ferreira AM, de Oliveira LC, Bierrenbach AL, Haikal DSA, Sabino EC, Cardoso CS, Nunes MCP. Martins Barros IM, et al. PLoS One. 2021 Nov 4;16(11):e0258767. doi: 10.1371/journal.pone.0258767. eCollection 2021. PLoS One. 2021. PMID: 34735475 Free PMC article.
• The Immune Response to Trypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine Development.

  Rodrigues MM, Oliveira AC, Bellio M. Rodrigues MM, et al. J Parasitol Res. 2012;2012:507874. doi: 10.1155/2012/507874. Epub 2012 Feb 16. J Parasitol Res. 2012. PMID: 22496959 Free PMC article.
• Brazilian Guidelines for Cardiac Implantable Electronic Devices - 2023.

  Teixeira RA, Fagundes AA, Baggio Junior JM, Oliveira JC, Medeiros PTJ, Valdigem BP, Teno LAC, Silva RT, Melo CS, Elias Neto J, Moraes Júnior AV, Pedrosa AAA, Porto FM, Brito Júnior HL, Souza TGSE, Mateos JCP, Moraes LGB, Forno ARJD, D'Avila ALB, Cavaco DAM, Kuniyoshi RR, Pimentel M, Camanho LEM, Saad EB, Zimerman LI, Oliveira EB, Scanavacca MI, Martinelli Filho M, Lima CEB, Peixoto GL, Darrieux FCDC, Duarte JOP, Galvão Filho SDS, Costa ERB, Mateo EIP, Melo SL, Rodrigues TDR, Rocha EA, Hachul DT, Lorga Filho AM, Nishioka SAD, Gadelha EB, Costa R, Andrade VS, Torres GG, Oliveira Neto NR, Lucchese FA, Murad H, Wanderley Neto J, Brofman PRS, Almeida RMS, Leal JCF. Teixeira RA, et al. Arq Bras Cardiol. 2023 Jan 23;120(1):e20220892. doi: 10.36660/abc.20220892. Arq Bras Cardiol. 2023. PMID: 36700596 Free PMC article. English, Portuguese. No abstract available.
• Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine.

  Mesquita RD, Carneiro AB, Bafica A, Gazos-Lopes F, Takiya CM, Souto-Padron T, Vieira DP, Ferreira-Pereira A, Almeida IC, Figueiredo RT, Porto BN, Bozza MT, Graça-Souza AV, Lopes AH, Atella GC, Silva-Neto MA. Mesquita RD, et al. Infect Immun. 2008 Dec;76(12):5543-52. doi: 10.1128/IAI.00683-08. Epub 2008 Sep 15. Infect Immun. 2008. PMID: 18794282 Free PMC article.